Insulin Degludec/Insulin Aspart: A Novel Co-formulation for Insulin Intensification.
作者信息
Mohan V, Das A K, Joshi Shashank R
出版信息
J Assoc Physicians India. 2015 May;63(5 Suppl):6-7.
PMID:26548028
Abstract
摘要
相似文献
1
Insulin Degludec/Insulin Aspart: A Novel Co-formulation for Insulin Intensification.
J Assoc Physicians India. 2015 May;63(5 Suppl):6-7.
2
A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (BEGIN: VICTOZA ADD-ON).
Diabetes Obes Metab. 2014 Jul;16(7):636-44. doi: 10.1111/dom.12262. Epub 2014 Feb 11.
3
Clinical considerations for use of insulin degludec/insulin aspart in Japanese patients.
Expert Opin Biol Ther. 2018 Jan;18(1):77-85. doi: 10.1080/14712598.2018.1389888. Epub 2017 Oct 20.
4
Use of Insulin Degludec/Insulin Aspart in the Management of Diabetes Mellitus: Expert Panel Recommendations on Appropriate Practice Patterns.
Front Endocrinol (Lausanne). 2021 Mar 12;12:616514. doi: 10.3389/fendo.2021.616514. eCollection 2021.
5
Treating to target in type 2 diabetes: the BEGIN trial programme.
J Assoc Physicians India. 2014 Jan;62(1 Suppl):21-6.
6
Insulin analogues for recurrent severe hypoglycaemia.
Lancet Diabetes Endocrinol. 2014 Jul;2(7):529-30. doi: 10.1016/S2213-8587(14)70105-6. Epub 2014 May 2.
7
Insulin degludec (Tresiba)--a new long-acting insulin for diabetes.
Med Lett Drugs Ther. 2015 Dec 7;57(1483):163-4.
8
Degludec, a new ultra-long-acting basal insulin for the treatment of diabetes mellitus type 1 and 2: advances in clinical research.
Endocrinol Nutr. 2014 Mar;61(3):153-9. doi: 10.1016/j.endonu.2013.03.012. Epub 2013 Jul 25.
9
Insulin degludec for diabetes mellitus.
Drug Ther Bull. 2013 Jul;51(7):78-81. doi: 10.1136/dtb.2013.7.0190.
10
[Diabetes mellitus type 1 and 2. Flexible therapy with insulin degludec].
Med Monatsschr Pharm. 2014 Jul;37(7):273-4.
Zotero 插件